Chemoprevention of bilirubin encephalopathy with a nanoceutical agent

Autor: Aniruddha, Adhikari, Vinod K, Bhutani, Susmita, Mondal, Monojit, Das, Soumendra, Darbar, Ria, Ghosh, Nabarun, Polley, Anjan Kumar, Das, Siddhartha Sankar, Bhattacharya, Debasish, Pal, Asim Kumar, Mallick, Samir Kumar, Pal
Rok vydání: 2022
Předmět:
Zdroj: Pediatric Research. 93:827-837
ISSN: 1530-0447
0031-3998
DOI: 10.1038/s41390-022-02179-5
Popis: Targeted rapid degradation of bilirubin has the potential to thwart incipient bilirubin encephalopathy. We investigated a novel spinel-structured citrate-functionalized trimanganese tetroxide nanoparticle (C-MnSevere neonatal unconjugated hyperbilirubinemia (SNH) was induced in neonatal C57BL/6j mice model with phenylhydrazine (PHz) intoxication. Efficiency of the nanodrug on both in vivo bilirubin degradation and amelioration of bilirubin encephalopathy and associated neurobehavioral sequelae were evaluated.Single oral dose (0.25 mg kgThis study demonstrates the in vivo capacity of this novel nanodrug to reduce systemic and neural bilirubin load and reverse bilirubin-induced neurotoxicity. Further compilation of a drug-safety-dossier is warranted to translate this novel therapeutic chemopreventive approach to clinical settings.None of the current pharmacotherapeutics treat severe neonatal hyperbilirubinemia (SNH) to prevent risks of neurotoxicity. In this preclinical study, a newly investigated nano-formulation, citrate-functionalized Mn
Databáze: OpenAIRE
Externí odkaz: